Prostate Cell News Volume 14.46 | Dec 1 2023

    0
    12








    2023-12-01 | PCN 14.46


    Prostate Cell News by STEMCELL Technologies
    Vol. 14.46 – 1 December, 2023
    TOP STORY

    Chromatin Accessibility and Pioneer Factor FOXA1 Restrict Glucocorticoid Receptor Action in Prostate Cancer

    Researchers detected that the replacement of androgen receptor by glucocorticoid receptor in enzalutamide-exposed prostate cancer cells occured almost exclusively at pre-accessible chromatin sites displaying FOXA1 occupancy.
    [Nucleic Acids Research]

    Full Article

    Graphical Abstract
    Discover new celli Isolation technologies
    PUBLICATIONSRanked by the impact factor of the journal

    The ELAVL3/MYCN Positive Feedback Loop Provides a Therapeutic Target for Neuroendocrine Prostate Cancer

    The authors demonstrated that the RNA-binding protein ELAVL3 was specifically upregulated in neuroendocrine prostate cancer and that overexpression of ELAVL3 alone was sufficient to induce the neuroendocrine phenotype in prostate adenocarcinoma.
    [Nature Communications]

    Full Article

    Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor-Associated Macrophages in Prostate Cancer

    Investigators demonstrated that tumor-associated macrophages-secreted taurine suppressed ferroptosis in prostate cancer by activating the Liver X receptor alpha/Stearoyl-Coenzyme A desaturase 1 pathway.
    [Advanced Science]

    Full Article

    Glucocorticoid Treatment Influences Prostate Cancer Cell Growth and the Tumor Microenvironment via Altered Glucocorticoid Receptor Signaling in Prostate Fibroblasts

    Scientists observed changes which affected proliferation, colony formation, and 3D-spheroid growth of multiple epithelial prostate cancer cell models.
    [Oncogene]

    Full Article

    CircTENM3 Inhibits Tumor Progression via the miR-558/RUNX3 Axis in Prostate Cancer

    CCK8 assays, EdU assays, Scratch assay and Transwell migration assay were conducted to detect the role of circTENM3 in prostate cancer cells in vitro.
    [Journal of Translational Medicine]

    Full Article

    Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer

    The compound discovered exhibited high selectivity among 215 kinases and significantly suppressed the proliferation and metastasis of prostate cancer cells in vitro.
    [Journal Of Medicinal Chemistry]

    Abstract

    RCC2 Promotes Prostate Cancer Cell Proliferation and Migration through Hh/GLI1 Signaling Pathway and Cancer Stem-Like Cells

    Researchers explored the function of regulator of chromosome condensation 2 (RCC2) on prostate cancer (PCa) development. They found that RCC2 promoted PCa development through Hh/Gli1 signaling pathway via regulating epithelial-mesenchymal transition and cancer stem-like cells.
    [Biology Direct]

    Full Article

    Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition

    Scientists monitored cell viability in organoids, tumor volume, and PSA secretion in patient-derived xenografts and analyzed cell cycle and signaling pathway alterations.
    [Molecular Cancer Therapeutics]

    Abstract

    Anticancer Actions of Carnosine in Cellular Models of Prostate Cancer

    The authors investigated the effect of carnosine on cell proliferation and metabolism in both a primary cultured androgen-resistant human prostate cancer cell line, and murine cells.
    [Journal Of Cellular And Molecular Medicine]

    Full Article
    Learn strategies and tips for choosing which scientific conferences to attend.
    REVIEWS

    Autocrine/Paracrine Growth Hormone in Cancer Progression

    In a number of cancers, including carcinoma of the mammary gland, endometrium, liver, prostate, and colon, the expression of growth hormone is independently associated with more advanced clinicopathologic parameters of the cancer.
    [Endocrine-Related Cancer]

    Abstract
    INDUSTRY AND POLICY NEWS

    World’s Biggest Set of Human Genome Sequences Opens to Scientists

    The whole genomes of 500,000 people in the UK Biobank will help researchers to probe our genetic code for links to disease.
    [Nature News]

    Editorial
    FEATURED EVENT

    UROtech24

    January 25 – 27, 2024
    Vienna, Austria

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientists – Regulatory Lymphocytes & Tissue Resident Cells Crosstalk

    Institut Necker Enfants Malades – Paris, France

    Research Scientist – Genitourinary Medical Oncology

    The University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Postdoctoral Fellow – Prostate Cancer

    Cedars-Sinai – Los Angeles, California, United States

    Assistant/Associate Professor – Prostate Cancer

    Fred Hutchinson Cancer Center – Seattle, Washington, United States

    Research Assistant – Epigenetics

    Babraham Institute – Cambridge, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2